Antibacterial Susceptibility Pattern of Gram Negative Bacteria Isolated from Patients with Urinary Tract Infection
Bacteria Causing Urinary Tract Infection
DOI:
https://doi.org/10.54393/fbt.v1i01.1Keywords:
E. coli, Urinary Tract Infection, Antibiotics, ResistantAbstract
In clinical setting, urinary tract infections (UTIs) rank second among infectious presentations. Each year, around 150 million people receive a UTI diagnosis worldwide. Objectives: To determine the antibacterial sensitivity of meropenem, imipenem and ciprofloxacin against bacteria isolated from patients presented with Urinary Tract Infection. Methods: This Descriptive type Cross-sectional study was carried out at Clinical Microbiology Laboratory, Pathology Department of King Edward Medical University. A total of 100 patients were included that had Urinary Tract Infections. Urine culture was done using standardized Cysteine lactose electrolyte deficient (CLED) agar. Gram reaction, morphology, and biochemical properties were used to identify bacterial pathogens. Antibiotic sensitivity of the selected Gram negative bacteria was observed by using the Kirby Bauer method for antibiotic susceptibility. Results: The bacteria isolated were E. coli (62%), Klebsiella spp. (11%), Candida spp. (8%), Pseudomonas aeruginosa (7%), Proteus spp. (4%), Staphylococcus spp. (3%), Staphylococcus saprophyticus (3%) and Enterobacter spp. (2%). Sensitivity pattern for Ciprofloxacin was 20 (23.3%) sensitive and 66 (76.7%) resistant. Similarly 87.2% were sensitive to Meropenem and 12.8% were resistant. While for Imipenem 95.3% were sensitive and 4.7% were resistant. Conclusions: It was concluded that UTI most commonly caused by E. coli which is a gram negative bacteria followed by Klebsiella, Pseudomonas, Proteus and Enterobacter. Other microorganisms such as Staphylococcus spp., Staphylococcus saprophyticus and Candida spp. were also isolated in least amount. Antimicrobial susceptibility showed that Gram negative isolates of uropathogens were highly resistant against Ciprofloxacin and showed sensitivity against Imipenem and Meropenem
References
Kunin CM. Urinary tract infections and pyelonephritis. Cecil text book of medicine. 2000: 613-7.
Gonzalez CM and Schaeffer AJ. Treatment of urinary tract infection: what's old, what's new, and what works. World journal of urology. 1999 Dec; 17(6): 372-82. doi: 10.1007/s003450050163
Schappert SM. Ambulatory care visits to physician offices, hospital outpatient departments, and emergency departments. United States,1997. Vital Health Statistic. 1997; 143: 1-39.
Laupland KB, Ross T, Pitout JD, Church DL, Gregson DB. Community-onset urinary tract infections: a population-based assessment. Infection. 2007 Jun; 35(3): 150-3. doi: 10.1007/s15010-007-6180-2
Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Disease-a-month. 2003 Feb; 49(2): 53-70. doi: 10.1067/mda.2003.7
Delanghe JR, Kouri TT, Huber AR, Hannemann-Pohl K, Guder WG, Lun A, et al. The role of automated urine particle flow cytometry in clinical practice. Clinica Chimica Acta. 2000 Nov; 301(1-2): 1-8. doi: 10.1016/S0009-8981(00)00342-9
Ali AS, Townes CL, Hall J, Pickard RS. Maintaining a sterile urinary tract: the role of antimicrobial peptides. The Journal of urology. 2009 Jul; 182(1): 21-8. doi: 10.1016/j.juro.2009.02.124
Justice SS, Hunstad DA, Seed PC, Hultgren SJ. Filamentation by Escherichia coli subverts innate defenses during urinary tract infection. Proceedings of the National Academy of Sciences. 2006 Dec 26; 103(52): 19884-9. doi: 10.1073/pnas.0606329104
Blair KA. Evidence-based management of urinary tract infections across the lifespan: Current update. The Journal for Nurse Practitioners. 2007 Oct; 3(9): 629-32. doi: 10.1016/j.nurpra.2007.07.020
Farajnia S, Alikhani MY, Ghotaslou R, Naghili B, Nakhlband A. Causative agents and antimicrobial susceptibilities of urinary tract infections in the northwest of Iran. International journal of infectious diseases. 2009 Mar; 13(2): 140-4. doi: 10.1016/j.ijid.2008.04.014
Karram M and Siddighi S. Lower urinary tract infection. Ostergards’s urogynecology and pelvic floor dysfunction. 2008: 148-69.
Yüksel S, Öztürk B, Kavaz A, Özçakar ZB, Acar B, Güriz H, et al. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. International journal of antimicrobial agents. 2006 Nov; 28(5): 413-6. doi: 10.1016/j.ijantimicag.2006.08.009
Wayne PA. National committee for clinical laboratory standards. Performance standards for antimicrobial disc susceptibility testing. 2002; 12: 01-53.
Khattak AM, Khan HU, Mashud IU, Shah SH, Ashiq B. Antimicrobial sensitivity pattern of urine isolates from asymptomatic bacteriuria during pregnancy. Biomedica. 2006; 22(1): 67-70.
Awaness AM, Al-Saadi MG, Aadoas SA. Antibiotics resistance in recurrent urinary tract infection. Kufa medical journal. 2000; 3: 159.
Gales AC, Jones RN, Gordon KA, Sader HS, Wilke WW, Beach ML, et al. Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998). Journal of Antimicrobial Chemotherapy. 2000 Mar; 45(3): 295-303. doi: 10.1093/jac/45.3.295
Daoud Z, Afif C. Escherichia coli isolated from urinary tract infections of Lebanese patients between 2000 and 2009: epidemiology and profiles of resistance. Chemotherapy Research and Practice. 2011; 2011. doi: 10.1155/2011/218431
Amin, M., M. Manijeh and P. Zohreh. Study of bacteria isolated from urinary tract infections and determination of their susceptibility to antibiotics. Jundishapur journal of Microbiology. 2009; 2: 118-23.
Officer H and Zareef S. The Culture and Sensitivity Pattern of Uropathogens Detected at Benazir Bhutto Hospital. Annals of Pakistan Institute of Medical Sciences. 2009; 5(2): 121-5.
Greer LG, Roberts SW, Sheffield JS, Rogers VL, Hill JB, Mcintire DD, et al. Ampicillin resistance and outcome differences in acute antepartum pyelonephritis. Infectious diseases in obstetrics and gynecology. 2008 Oct; 2008. doi: 10.1155/2008/891426
Jones ME, Karlowsky JA, Draghi DC, Thornsberry C, Sahm DF, Nathwani D. Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy. International journal of antimicrobial agents. 2003 Oct; 22(4): 406-19. doi: 10.1016/S0924-8579(03)00154-7
Shah SH. Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype. Journal of Pakistan Medical Association. 2002; 52(407).
Sabir N, Khan E, Sheikh L, Hasan R. Impact of antibiotic usage on resistance in microorganisms; urinary tract infections with E-coli as a case in point. Journal of Pakistan Medical Association. 2004; 54(9): 472.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Futuristic Biotechnology
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. For comments editor@fbtjournal.com